Clinica Baviera S.A. Logo

Clinica Baviera S.A.

ISIN: ES0119037010 | Ticker: CBAV | LEI: 959800CR1BA43ZK65T94
Sector: Health CareSub-Industry: Health Care Services
Country: Spain

About Clinica Baviera S.A.

Company Description

Clínica Baviera is a European reference in the diagnosis, treatment and follow-up of all types of ophthalmological disorders. Our state-of-the-art technologies allow us to offer a solution to the problems of myopia, hyperopia, astigmatism and presbyopia. In addition, we are specialists in the medical and surgical treatment of problems derived from cataracts, glaucoma, vitreoretinal pathologies, strabismus, ocular plastic surgery, problems of the periocular area, neuro-ophthalmology and corneal diseases. We have a network of more than 90 clinics in four European countries (Spain, Germany, Austria and Italy) and a medical staff of more than 200 ophthalmologists, who have performed more than one million treatments.

Year founded

1992

Served area

Europe

Headcount

200

Headquarters

Po de la Castellana 20, 28046 Madrid – Spain

Financial statements

Download as Excel
Line item in (eur) 01.01.2020 01.01.2021 02.01.2021 01.01.2022
Assets N/A 120,921,729.00 N/A 133,809,191.00
Noncurrent Assets N/A 89,543,855.00 N/A 95,886,460.00
Property Plant And Equipment N/A 71,402,884.00 N/A 77,253,249.00
Goodwill N/A 14,615,838.00 N/A 14,615,838.00
Other Intangible Assets N/A 564,265.00 N/A 997,795.00
Investment Accounted For Using Equity Method N/A 236,855.00 N/A 189,894.00
Deferred Tax Assets N/A 908,903.00 N/A 976,066.00
Other Noncurrent Financial Assets N/A 1,815,110.00 N/A 1,853,618.00
Current Assets N/A 31,377,874.00 N/A 37,922,731.00
Inventories N/A 1,641,524.00 N/A 1,932,946.00
Trade And Other Current Receivables N/A 2,279,594.00 N/A 3,393,863.00
Current Receivables From Taxes Other Than Income Tax N/A 33,503.00 N/A 21.00
Current Tax Assets Current N/A 63,478.00 N/A 53,174.00
Other Current Financial Assets N/A 16,113,928.00 N/A 22,471,366.00
Cash and cash equivalents 3,921,368.00 10,821,669.00 N/A 9,801,026.00
Other Current Assets N/A 424,178.00 N/A 270,335.00
Equity And Liabilities N/A 120,921,729.00 N/A 133,809,191.00
Equity N/A 44,904,399.00 44,904,399.00 55,394,068.00
Issued Capital N/A 1,630,758.00 N/A 1,630,758.00
Retained Earnings N/A 23,951,905.00 N/A 28,849,606.00
Share Premium N/A 4,893,814.00 N/A 4,893,814.00
Treasury Shares N/A 48,692.00 N/A 75,882.00
Equity Attributable To Owners Of Parent N/A 44,491,994.00 N/A 54,603,670.00
Noncontrolling Interests N/A 412,405.00 N/A 790,398.00
Noncurrent Liabilities N/A 43,669,472.00 N/A 42,548,482.00
Other Longterm Provisions N/A 1,614,183.00 N/A 2,364,790.00
Noncurrent Payables On Social Security And Taxes Other Than Income Tax N/A 2,259,879.00 N/A 2,739,426.00
Deferred Tax Liabilities N/A 346,941.00 N/A 292,448.00
Other Noncurrent Financial Liabilities N/A 31,138,420.00 N/A 33,419,459.00
Noncurrent Portion Of Noncurrent Unsecured Bank Loans Received N/A 10,569,928.00 N/A 6,471,785.00
Current Liabilities N/A 32,347,858.00 N/A 35,866,641.00
Other Shortterm Provisions N/A 177,864.00 N/A 166,294.00
Trade And Other Current Payables N/A 9,937,010.00 N/A 12,981,067.00
Current Tax Liabilities Current N/A 4,222,767.00 N/A 2,923,080.00
Other Current Financial Liabilities N/A 9,970,333.00 N/A 12,336,293.00
Current Unsecured Bank Loans Received And Current Portion Of Noncurrent Unsecured Bank Loans Received N/A 5,780,005.00 N/A 4,103,230.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
Revenue 122,625,591.00 172,730,250.00
Other Income 2,257,385.00 677,283.00
Other Work Performed By Entity And Capitalised 0.00 515,702.00
Raw Materials And Consumables Used 15,253,192.00 22,000,122.00
Employee Benefits Expense 48,976,749.00 62,048,942.00
Depreciation And Amortisation Expense 13,545,027.00 14,093,894.00
Other Expense By Nature 26,598,865.00 36,318,028.00
Other Gains Losses 0.00 0.00
Profit Loss From Operating Activities 20,509,143.00 39,429,182.00
Finance Income 8,005.00 3,191.00
Finance Costs 535,091.00 458,301.00
Profit Loss Before Tax 20,186,062.00 38,899,356.00
Income Tax Expense Continuing Operations 6,053,434.00 10,967,857.00
Profit (loss) 14,132,628.00 27,931,499.00
Profit Loss Attributable To Owners Of Parent 13,941,697.00 27,389,527.00
Profit Loss Attributable To Noncontrolling Interests 190,931.00 541,972.00
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022
Profit (loss) N/A 14,132,628.00 27,931,499.00
Adjustments For Finance Costs N/A 535,091.00 458,301.00
Adjustments For Decrease Increase In Other Operating Receivables N/A 555,674.00 -909,103.00
Adjustments For Provisions N/A 657,452.00 661,268.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets N/A 0.00 33,067.00
Other Adjustments To Reconcile Profit Loss N/A -1,508,795.00 95,052.00
Cash Flows From Used In Operating Activities N/A 31,455,529.00 46,856,588.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 0.00 50,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 7,818,598.00 10,575,188.00
Interest Received Classified As Investing Activities N/A 8,005.00 3,191.00
Cash Flows From Used In Investing Activities N/A -21,401,741.00 -17,081,246.00
Payments To Acquire Or Redeem Entitys Shares N/A 190,682.00 491,372.00
Payments Of Other Equity Instruments N/A 0.00 0.00
Proceeds From Borrowings Classified As Financing Activities N/A 10,000,000.00 0.00
Repayments Of Borrowings Classified As Financing Activities N/A 5,905,971.00 5,774,917.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 7,026,672.00 7,651,984.00
Dividends Paid Classified As Financing Activities N/A 0.00 17,348,242.00
Interest Paid Classified As Financing Activities N/A 123,956.00 112,576.00
Cash Flows From Used In Financing Activities N/A -3,153,488.00 -30,795,985.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 6,900,300.00 -1,020,643.00
Cash and cash equivalents 3,921,368.00 10,821,669.00 9,801,026.00

Please note that some sums might not add up.

Filings & Publications

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2019

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2018

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2017

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2016

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2015

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2014

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2013

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2012

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2011

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2010

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2009

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2008

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2007

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2006

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2005

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2004

Report
Q1
H1
Q3
FY
Consolidated Report
ESP
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

ES0119037010

LEI

959800CR1BA43ZK65T94

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Services

Listed Stock Exchange

Bolsa de Madrid

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.